These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37048531)

  • 41. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location.
    Aziz DA; Moin M; Majeed A; Sadiq K; Biloo AG
    Pak J Med Sci; 2017; 33(4):793-797. PubMed ID: 29067041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
    Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
    J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
    Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia.
    Mangat BK; Evaschen C; Lee T; Yoshida EM; Salh B
    Can J Gastroenterol; 2011 Feb; 25(2):73-7. PubMed ID: 21321677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
    Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
    World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
    Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
    Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study.
    Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B
    Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time trend analysis and demographic features of inflammatory bowel disease in Tehran.
    Balaii H; Asadzadeh Aghdaei H; Farnood A; Habibi M; Mafi AA; Firouzi F; Sharifian A; Shahrokh S; Lahmi F; Zojaji H; Naderi N; Zali MR
    Gastroenterol Hepatol Bed Bench; 2015; 8(4):253-61. PubMed ID: 26468345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
    Lo B; Julsgaard M; Vester-Andersen MK; Vind I; Burisch J
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1130-1136. PubMed ID: 29979218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE.
    Martins KR; Araújo JM; Cruz ÁC; Luiz-Ferreira A
    Arq Gastroenterol; 2021; 58(3):377-383. PubMed ID: 34705974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survey of inflammatory bowel diseases in India.
    Makharia GK; Ramakrishna BS; Abraham P; Choudhuri G; Misra SP; Ahuja V; Bhatia SJ; Bhasin DK; Dadhich S; Dhali GK; Desai DC; Ghoshal UC; Goswami BD; Issar SK; Jain AK; Jayanthi V; Loganathan G; Pai CG; Puri AS; Rana SS; Ray G; Singh SP; Sood A;
    Indian J Gastroenterol; 2012 Dec; 31(6):299-306. PubMed ID: 23073755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.
    Høivik ML; Reinisch W; Cvancarova M; Moum B;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):69-76. PubMed ID: 24172277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease.
    Wang HY; Li Y; Li JJ; Jiao CH; Zhao XJ; Li XT; Lu MJ; Mao XQ; Zhang HJ
    World J Clin Cases; 2019 Aug; 7(16):2189-2203. PubMed ID: 31531314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.
    Tozun N; Atug O; Imeryuz N; Hamzaoglu HO; Tiftikci A; Parlak E; Dagli U; Ulker A; Hulagu S; Akpinar H; Tuncer C; Suleymanlar I; Ovunc O; Hilmioglu F; Aslan S; Turkdogan K; Bahcecioglu HI; Yurdaydin C;
    J Clin Gastroenterol; 2009 Jan; 43(1):51-7. PubMed ID: 18724251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of selected neutrophil protein plasma concentrations in the diagnosis of Crohn's disease and ulcerative colitis - a preliminary report.
    Pawlica-Gosiewska D; Solnica B; Gawlik K; Cibor D; Mach T; Fedak D; Owczarek D
    Postepy Hig Med Dosw (Online); 2017 Apr; 71(0):243-253. PubMed ID: 28397705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.